| Views | |
|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 96 |
| May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | |
|---|---|---|---|---|---|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 6 | 2 | 8 | 3 | 2 | 2 | 2 |
| Views | |
|---|---|
| 2020_Xie_etal.pdf | 48 |
